0.55CNY
889.54 MCNY
2.46 BCNY
588.67 M
About JAFRON BIOMEDICAL
Sector
Industry
CEO
Fan Dong
Website
Headquarters
Zhuhai
Employees (FY)
3 K
Founded
1989
ISIN
CNE100002995
FIGI
BBG006FTHNB5
Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include HA series hemoperfusion cartridge, BS bilirubin adsorption column, DNA immunoadsorption column, hemoperfusion machine, blood purification machine and other products. The company was founded on December 19, 1989 and is headquartered in Zhuhai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 300529 is 23.30 CNY — it has increased by 1.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange JAFRON BIOMEDICAL stocks are traded under the ticker 300529.
JAFRON BIOMEDICAL is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
300529 stock is 2.63% volatile and has beta coefficient of 1.43. Check out the list of the most volatile stocks — is JAFRON BIOMEDICAL there?
300529 earnings for the last quarter are 0.16 CNY per share, whereas the estimation was 0.38 CNY resulting in a −57.89% surprise. The estimated earnings for the next quarter are 0.47 CNY per share. See more details about JAFRON BIOMEDICAL earnings.
Yes, you can track JAFRON BIOMEDICAL financials in yearly and quarterly reports right on TradingView.
300529 stock has risen by 2.92% compared to the previous week, the month change is a 2.78% rise, over the last year JAFRON BIOMEDICAL has showed a 19.66% decrease.
300529 net income for the last quarter is 146.15 M CNY, while the quarter before that showed 80.98 M CNY of net income which accounts for 80.48% change. Track more JAFRON BIOMEDICAL financial stats to get the full picture.
Today JAFRON BIOMEDICAL has the market capitalization of 18.06 B, it has decreased by 0.44% over the last week.
Yes, 300529 dividends are paid annually. The last dividend per share was 0.67 CNY. As of today, Dividend Yield (TTM)% is 2.93%. Tracking JAFRON BIOMEDICAL dividends might help you take more informed decisions.
JAFRON BIOMEDICAL dividend yield was 2.16% in 2022, and payout ratio reached 60.09%. The year before the numbers were 1.69% and 60.40% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 300529 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAFRON BIOMEDICAL stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 3.00 K employees. See our rating of the largest employees — is JAFRON BIOMEDICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JAFRON BIOMEDICAL technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JAFRON BIOMEDICAL stock shows the neutral signal. See more of JAFRON BIOMEDICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JAFRON BIOMEDICAL future price: according to them, 300529 price has a max estimate of 25.23 CNY and a min estimate of 25.23 CNY. Read a more detailed JAFRON BIOMEDICAL forecast: see what analysts think of JAFRON BIOMEDICAL and suggest that you do with its stocks.